ezabenlimab
Showing 1 - 12 of 12
Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer Trial (BI 765049, Ezabenlimab)
Not yet recruiting
- Gastrointestinal Cancer
- +5 more
- BI 765049
- Ezabenlimab
- (no location specified)
Oct 16, 2023
Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- Neuroendocrine Neoplasms
- BI 764532
- Ezabenlimab
- (no location specified)
May 25, 2023
Pancreatic Ductal Adenocarcinoma Trial in New York (VSV-GP154, ATP150, ATP152)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- VSV-GP154
- +3 more
-
New York, New YorkNYU Langone Health
May 4, 2023
Colorectal Cancer Trial (Ezabenlimab, BI 765063, Pembrolizumab)
Recruiting
- Colorectal Cancer
- Ezabenlimab
- +2 more
-
New York, New YorkMount Sinai School of Medicine
Jan 10, 2023
Solid Tumors Trial (BI 1703880, Ezabenlimab)
Not yet recruiting
- Solid Tumors
- BI 1703880
- Ezabenlimab
- (no location specified)
Aug 8, 2022
Solid Tumors Trial in Santa Monica, Winston-Salem (BI 1831169, ezabenlimab)
Recruiting
- Solid Tumors
- BI 1831169
- ezabenlimab
-
Santa Monica, California
- +1 more
Aug 23, 2022
Solid Tumors Trial in Canada, Japan, United States (BI 770371, ezabenlimab)
Recruiting
- Solid Tumors
- BI 770371
- ezabenlimab
-
Sarasota, Florida
- +4 more
Jan 10, 2023
Carcinoma, Squamous Cell of Head and Neck (HNSCC), Melanoma, NSCLC (NSCLC) Trial in Amsterdam (BI 765063, Ezabenlimab, [89Zr]Zr-
Recruiting
- Carcinoma, Squamous Cell of Head and Neck (HNSCC)
- +2 more
- BI 765063
- +4 more
-
Amsterdam, NetherlandsAmsterdam UMC Locatie VUMC
Jan 9, 2023
Tumors Trial in Worldwide (BI 765179, Ezabenlimab)
Recruiting
- Neoplasms
- BI 765179
- Ezabenlimab
-
Tucson, Arizona
- +6 more
Aug 23, 2022
Colorectal Tumors, NSCLC, Pancreatic Tumors, Carcinoma, Hepatocellular, Head and Neck Tumors, Gastrointestinal Tumors Trial in
Recruiting
- Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
- BI 765049
- ezabenlimab
-
Denver, Colorado
- +4 more
Jan 9, 2023
Glioblastoma Trial in Frankfurt (NK-92/5.28.z, Ezabenlimab)
Recruiting
- Glioblastoma
- NK-92/5.28.z
- Ezabenlimab
-
Frankfurt, Germany
- +1 more
Aug 12, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (BI 765063, Ezabenlimab, BI 836880)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- BI 765063
- +4 more
-
Saint Louis, Missouri
- +15 more
Aug 10, 2022